In Genital warts (Skin bumps on or around the genital or anal area) Qmica 12.5mg Cream is used for the treatment, control, prevention, & improvement of genital warts (Skin bumps on or around the genital or anal area). It effectively removes the warts, promotes healing of injured skin and helps in formation of new healthy layers of skin. In Actinic keratosis Actinic keratosis is an abnormal rough and scaly growth of skin, due to long-term exposure to the sun. These lesions can lead to skin cancer and need medical attention. Qmica 12.5mg Cream kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. This helps to prevent skin cancer and also improves the skin texture.Use it as prescribed by the doctor and follow all the instructions carefully. In Basal cell cancer Qmica 12.5mg Cream stimulates the immune system to release a number of chemicals called cytokines, which are important in fighting viruses and destroying cancer cells. When used to treat skin cancers and precancerous lesions it results in inflammation, which destroys the lesion. You may have to use Qmica 12.5mg Cream for several weeks. Continue using this medicine as directed by the doctor.
No interaction found/established
Qmica 12.5mg Cream may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Qmica 12.5mg Cream is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
No interaction found/established
No interaction found/established
No interaction found/established
If you miss a dose of Qmica 12.5mg Cream, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Dr Reddy's Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Glenmark Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)